Beginning in August 2020, those diagnosed with chronic pain and/or age-related macular degeneration will be eligible to receive medical cannabis recommendations.
Regulators are also amending the program to allow cannabis products to be sold in the form of powders, gum, lozenges, and sublingual tablets, among other formulations. State law does not allow for the sale of herbal cannabis.
Officials also announced that they would be expanding the total number of licensed dispensaries operating within the state.
An estimated 18,000 Minnesotans are registered to legally access medical cannabis products.
For more information, contact Carly Wolf, NORML State Policies Coordinator, at (202) 483-5500.